OCUL Net Income Growth
-39.08%TTM
Period ending:
OCUL TTM Net Income YoY %%
225.37%-1113.63%
2014-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
OCUL net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 47 observations from Dec 31, 2014 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -39.0772% | |
| -50.7428% | |
| -37.4319% | |
| -43.212% | |
| -56.654% | |
| -67.1881% | |
| -139.6775% | |
| -159.9809% | |
| -52.4975% | |
| -29.7836% | |
| -13.6518% | |
| -12.995% | |
| -179.1606% | |
| -299.7749% | |
| -984.0531% | |
| 32.8019% | |
| 68.4199% | |
| 83.0416% | |
| 95.7895% | |
| 8.0445% | |
| -0.0399% | |
| -44.34% | |
| -80.1927% | |
| -23.519% | |
| -39.0466% | |
| -43.297% | |
| -44.0061% | |
| -39.6419% | |
| -31.5587% | |
| -3.6137% | |
| 5.3766% | |
| 11.7659% | |
| 1.57% | |
| -22.5354% | |
| -41.7936% | |
| -48.4218% | |
| -28.5493% | |
| -15.987% | |
| -12.466% | |
| -14.712% | |
| -35.3617% | |
| -47.2038% | |
| -38.7462% | |
| -53.1675% | |
| -60.7431% | |
| -70.6161% | |
| -115.1235% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All OCUL financial metrics · OCUL stock overview · How to interpret financial metrics
